GloPID-R’s strength lies in coordinating the efforts of funders
Now that the COVID-19 pandemic has subsided and life is beginning to return to the way it was before, I think everyone has had an opportunity to look back on this period of turmoil.
As I look back, if I have one thing to share, it is the magnitude of the contribution of science and technology to the countermeasures to the epidemic. As the international community faced a public health crisis, we applied the scientific knowledge and technology that we had cultivated up to that point, making key contributions not only to the medical field but also to society in general. A simple example would be the development of m-RNA vaccines.
Honouring outgoing Board members
Honouring Shoji Miyagawa and Jeremy Farrar for their contributions as GloPID-R co-chairs
Following successful and productive terms on the GloPID-R Executive Board, two of our co-chairs – Shoji Miyagawa and Jeremy Farrar – stepped down in December 2022. It was a great pleasure for me to work alongside Shoji and Jeremy for many years as two very dedicated and valued members of GloPID-R. I would like to take this opportunity to thank them for their important contributions, which have shaped and advanced GloPID-R’s mission to ensure coordinated and effective preparedness and research response among funders to epidemics and pandemics.